COMPANIES WE HAVE INVESTED IN
CEO: Dr. Mike E. Gurney PHD, MBA
Tetra is committed to building a leading portfolio of clinical trial stage treatments, based on phosphodiesterase sub-type inhibitors for both neuroscience and non-neuroscience disorders. These are fields in which we believe Tetra is poised to deliver multiple novel treatments, with the potential to change patients’ lives.
|
CEO: Mr. Andrew Cook
TempoIQ is a real-time, scalable Internet-of-Things analytics platform. We provide tools to store, analyze, and monitor the time-series data that powers connected applications. Our service is offered as a private, dedicated instance of the full platform and we help IoT companies produce insights in milliseconds instead of months.
|
|
|